I am bullish on the top line data. I am also an MD and aware of the scientific process/publishing. It is very hard for this type of data with very high crossover, etc to get published in a journal such as NEJM. No doubt it will be published, I just don't think it's going to be in the NEJM/JAMA league.
News 
Market Data 
Discover 
AI
